Canakinumab Subcutaneous and Dextenza intraocular
Determining the interaction of Canakinumab Subcutaneous and Dextenza intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Dextran 40
- Canakinumab Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Canakinumab Subcutaneous-Dextran 75
- Canakinumab Subcutaneous-Dextran high molecular weight
- Canakinumab Subcutaneous-Dextranomer and Hyaluronate Derivatives (Deflux)
- Canakinumab Subcutaneous-Dextranomer and Hyaluronate Derivatives (Solesta)
- Dextenza intraocular-Canasa
- Dextenza intraocular-Canasa Pac rectal
- Dextenza intraocular-Canasa rectal
- Dextenza intraocular-Cancidas
- Dextenza intraocular-Candesartan
- Dextenza intraocular-Candesartan and Hydrochlorothiazide